Lilly’s Zepbound Outage Deepens as Almost All Doses Short (1)

Nearly all doses of Eli Lilly & Co.’s weight-loss drug Zepbound will now be in shortage through at least the beginning of summer as demand for the blockbuster injections continues to surge.

Only the lowest dose of Zepbound, a 2.5 milligram shot normally used for the first month of treatment, is listed as “available” through the first half of the year, according to the US Food and Drug Administration website. The agency had earlier said just two of six doses would be in limited supply through the end of April.

“We recognize this situation may cause a disruption in ...